fbpx

MS increases vascular mortality risk

MS increases vascular mortality risk Published: 28 May 2020 New research has found that having multiple sclerosis (MS) is associated with an increased risk of acute coronary syndrome (ACS), stroke, and death, and the findings cannot be explained by traditional risk factors.  Scientists found that participants with MS had a
Read More

Long-term fingolimod treatment may lessen disability

Long-term fingolimod treatment may lessen disability Published: 27 May 2020 Long-term treatment with fingolimod results in lesser disability in people with relapsing remitting multiple sclerosis (MS), a new study has found.  People treated with the drug for eight or more years had smaller increases in disability over the course of
Read More

Spasticity scale test not enough to show Sativex benefits

Spasticity scale test not enough to show Sativex benefits Published: 26 May 2020 A new study from Italy has found that Sativex, a type of medical cannabis licensed in the UK for some symptoms of multiple sclerosis MS, eases symptoms related to spasticity, even in those with no significant improvements
Read More

Obesity linked to faster optic nerve degeneration

Obesity linked to faster optic nerve degeneration Published: 07 May 2020 Being obese is linked to a faster degeneration of optic nerve tissue in people with multiple sclerosis (MS) than in those of a normal body weight, a new study has found.  Researchers at Johns Hopkins University, who conducted the
Read More

New technique to detect early-stage MS

New technique to detect early-stage MSPublished: 30 April 2020 Scientists have developed a new technique to diagnose early-stage multiple sclerosis (MS) and distinguish it from a similar autoimmune condition called neuromyelitis optica.  Brazilian researchers used a nanobiosensor, which was originally created to detect pollutants like herbicides and heavy metals, and
Read More

New subset of monocytes offers hope for MS treatment

New subset of monocytes offers hope for MS treatment Published: 29 April 2020 A new mouse model study has suggested targeting a subset of monocytes, a type of immune cell, might be a better way to treat multiple sclerosis (MS) than targeting all of the immune system’s cells, which is
Read More

We’re the sixth best charity to work for in the UK

We’re the sixth best charity to work for in the UK Published: 29 April 2020 MS-UK are excited to announce we have been named the sixth best charity to work for in Britain.  We scooped the accolade in Third Sector’s Best Charities to Work For, which recognises employers in the
Read More

Fruit peel compound may promote myelin repair

Fruit peel compound may promote myelin repair Published: 16 April 2020 A compound found in the peels of some fruits, such as apples and prunes, may reduce neuron damage and promote myelin repair, a mouse model study has found.  Scientists used laboratory-grade, purified ursolic acid and tested mice which were
Read More